BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients

To evaluate BRCA1/2 immunohistochemistry (IHC) as a screening test for germline BRCA1/2 in epithelial ovarian cancer (EOC), tumor tissue from 105 EOC patients who had germline BRCA mutations, including 9 BRCA1 mutations, 6 BRCA2 mutations and 90 no BRCA mutations, were studied. Paraffin-embedded tis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gynecol Oncol Rep
Autors principals: Manchana, Tarinee, Tantbirojn, Patou, Pohthipornthawat, Natkrita
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Special Section on Global Gynecologic Oncology; Edited by Linus Chuang and Thomas Randall
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7276421/
https://ncbi.nlm.nih.gov/pubmed/32529018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gore.2020.100582
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars